Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Oct 4;28(10-11):1225–1226. doi: 10.1038/s41417-021-00384-8

Correction: Inhibition of host Ogr1 enhances effector CD8+ T-cell function by modulating acidic microenvironment

Lin Cao 1,2,#, Weisha Li 2,#, Xingjiu Yang 2, Wenlong Zhang 2, Mengyuan Li 2, Haizeng Zhang 3, Chuan Qin 2, Xiaohong Chen 1,✉, Ran Gao 2,✉
PMCID: PMC9119266  PMID: 34608269

Correction to: Cancer Gene Ther 10.1038/s41417-021-00354-0, published online 22 June 2021

In Fig. 3A, the images of B220 and CD11C in Ogr1−/− group are the same. After checking with the raw data, we figured out the picture of CD11C in Ogr1−/− group were incorrectly copied during the overall picture layout. We have changed the picture and the attachment are the corrected Fig. 3A and Fig. 3.

graphic file with name 41417_2021_384_Fig1_HTML.jpg

Open in a new tab

Fig. 3A.

graphic file with name 41417_2021_384_Fig2_HTML.jpg

Open in a new tab

Fig. 3.

The original article has been corrected.

Contributor Information

Xiaohong Chen, Email: trchxh@163.com.

Ran Gao, Email: gaoran@cnilas.org.

Articles from Cancer Gene Therapy are provided here courtesy of Nature Publishing Group

RESOURCES